A Single-Pill HIV Treatment

By Richard Liang ’18 After extensive use of their multi-drug regimens, many HIV patients begin suffering from kidney impairment and decreased bone density. These pathologies have been recently associated with the chemical tenofovir in the medication regimens. As a response to this, the FDA approved Genvoya, a pill that minimizes tenofovir’s negative side effects. This novel pill combines dosages of active ingredients from standard medications, … Continue reading A Single-Pill HIV Treatment